Cargando…

Experience of danaparoid to treat vaccine-induced immune thrombocytopenia and thrombosis, VITT

BACKGROUND: Vaccine-induced immune thrombocytopenia and thrombosis (VITT) is triggered by nCOV-19 adenovirus-vectored vaccines against SARS-CoV2. Pathogenesis has been mainly related to platelet activation via PF4-reactive antibodies that activate platelets and may cross-react with heparin. Data con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Myllylahti, Lasse, Pitkänen, Hanna, Magnani, Harry, Lassila, Riitta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814786/ https://www.ncbi.nlm.nih.gov/pubmed/35120527 http://dx.doi.org/10.1186/s12959-021-00362-y

Ejemplares similares

Vaccine‐induced Immune Thrombocytopenia and Thrombosis (VITT)
por: Makris, Michael, et al.
Publicado: (2021)

Vaccine-induced thrombosis and thrombocytopenia (VITT); Exploring the unknown
por: Sunder, Ashok, et al.
Publicado: (2022)

Vaccination-induced thrombocytopenia and thrombosis (VITT) and pre-VITT: Do not miss (or misdiagnose) the new member of the thrombotic thrombocytopenias family
por: Noyé, Mickaël, et al.
Publicado: (2022)

Vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Warkentin, Theodore E.
Publicado: (2022)

Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Greinacher, Andreas, et al.
Publicado: (2022)

Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Gabarin, Nadia, et al.
Publicado: (2022)

Late-Onset Vaccine-Induced Immune Thombotic Thrombocytopenia (VITT) with Cerebral Venous Sinus Thrombosis
por: Saleh, Maruan, et al.
Publicado: (2022)

Understanding vaccine‐induced thrombotic thrombocytopenia (VITT)
por: Dix, Caroline, et al.
Publicado: (2022)

Vaccine-induced thrombosis and thrombocytopenia (VITT) in Ireland: A review of cases and current practices
por: Swan, D., et al.
Publicado: (2021)

Renal Vein Thrombosis and Pulmonary Embolism Secondary to Vaccine-induced Thrombotic Thrombocytopenia (VITT)
por: Cliff-Patel, Nikita, et al.
Publicado: (2021)

Pathophysiology of Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT) and Vaccine-Induced Thrombocytopenic Thrombosis (VITT) and Their Diagnostic Approach in Emergency
por: Di Micco, Pierpaolo, et al.
Publicado: (2021)

Arterial intracranial thrombosis as the first manifestation of vaccine-induced immune thrombotic thrombocytopenia (VITT): a case report
por: Mancuso, Michelangelo, et al.
Publicado: (2022)

Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT)—Insights from Clinical Cases, In Vitro Studies and Murine Models
por: Dabbiru, Venkata A. S., et al.
Publicado: (2023)

Usefulness of Danaparoid sodium in patients with Heparin-induced thrombocytopenia after cardiac surgery
por: Foroughinia, Farzaneh, et al.
Publicado: (2015)

Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis
por: Marchandot, Benjamin, et al.
Publicado: (2021)

COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) and Cerebral Venous Sinus Thrombosis (CVST)- Lessons for India
por: Khan, Erum, et al.
Publicado: (2022)

Persistence of Ad26.COV2.S‐associated vaccine‐induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies
por: Kanack, Adam J., et al.
Publicado: (2022)

AZD-1222: Vaccine-induced thrombosis with thrombocytopenia (VITT) and arterial and venous thrombotic stroke : case report
Publicado: (2022)

Vaccine-induced immune thrombocytopaenia and thrombosis (VITT) after COVID-19 vaccination
por: Ribeiro, Maria Inês, et al.
Publicado: (2022)

Caution in Using the Activated Partial Thromboplastin Time to Monitor Argatroban in COVID-19 and Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT)
por: Guy, Susan, et al.
Publicado: (2021)

Vaccine-induced immune thrombotic thrombocytopenia (VITT) with cerebral venous sinus thrombosis (CVST): a case report from Malaysia
por: Liam, Christopher Chin Keong, et al.
Publicado: (2022)

COVID-19 Adenoviral Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT), COVID-19-Related Thrombosis, and the Thrombotic Thrombocytopenic Syndromes
por: Allas, Gewil Daniella Olipas, et al.
Publicado: (2022)

A case report of vaccine-induced immune thrombotic thrombocytopenia (VITT) with genetic analysis
por: Mendes-de-Almeida, Daniela P., et al.
Publicado: (2023)

Audit of pathology requesting behaviour in the setting of vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Maclean, Marsali, et al.
Publicado: (2022)

Most cases of Thrombosis and Thrombocytopenia Syndrome (TTS) post ChAdOx-1 nCov-19 are Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT)
por: Makris, Michael, et al.
Publicado: (2021)

Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India
por: John, Christy V., et al.
Publicado: (2022)

Role of Anticoagulation and IVIG in Treatment of Vaccine-Induced Thrombotic Thrombocytopenia (VITT)
por: Tariq, Anosha, et al.
Publicado: (2022)

Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients
por: Hayashi, Takehiro, et al.
Publicado: (2019)

Vaccine‐induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources
por: Greinacher, Andreas, et al.
Publicado: (2022)

Microsurgical complication associated with vaccine-induced immune thrombotic thrombocytopenia (VITT): A case report
por: Hung, Chen-Ting, et al.
Publicado: (2023)

The Clinicalpathological Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Following ChAdOx1 (AstraZeneca AZD1222) Vaccination and Case Outcomes in Australia
por: Tran, Huyen, et al.
Publicado: (2022)

Vaccine‐induced immune thrombotic thrombocytopenia (VITT) – a novel clinico‐pathological entity with heterogeneous clinical presentations
por: Lavin, Michelle, et al.
Publicado: (2021)

Acute ST-segment elevation myocardial infarction secondary to vaccine-induced immune thrombosis with thrombocytopaenia (VITT)
por: Flower, Luke, et al.
Publicado: (2021)

Editorial: SARS-CoV-2 mRNA Vaccines and the Possible Mechanism of Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)
por: Parums, Dinah V.
Publicado: (2021)

Upregulation of Coagulation Factor VIII and Fibrinogen After Pulmonary Endarterectomy in Patients with Chronic Thromboembolic Pulmonary Hypertension
por: Myllylahti, Lasse, et al.
Publicado: (2023)

Vaccine‐induced immune thrombotic thrombocytopenia (VITT) after SARS‐CoV‐2 vaccination: Two cases from Germany with unusual presentation
por: Edmonds, Rhea, et al.
Publicado: (2023)

Characterization of Danaparoid Complex Extractive Drug by an Orthogonal Analytical Approach
por: Gardini, Cristina, et al.
Publicado: (2017)

Understanding vaccine-induced immune thrombocytopenia and thrombosis
por: Hunt, B.
Publicado: (2021)

Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US
por: Rodriguez, Elsa V. C., et al.
Publicado: (2021)

Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection
por: McGonagle, Dennis, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rpkp8s92md09cfg2bme9p0cg0v